Search Results - Brian Topp

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Incorporating lesion-to-lesion heterogeneity into early oncology decision making by Rukmini Kumar, Timothy Qi, Yanguang Cao, Yanguang Cao, Brian Topp

    Published in Frontiers in Immunology (2023-06-01)
    Get full text
    Article


  2. 2

    A bootstrapping method to optimize go/no‐go decisions from single‐arm, signal‐finding studies in oncology by Raunak Dutta, Aparna Mohan, Jacqueline Buros‐Novik, Gregory Goldmacher, Omobolaji O. Akala, Brian Topp

    Get full text
    Article


  3. 3

    Beyond the single average tumor: Understanding IO combinations using a clinical QSP model that incorporates heterogeneity in patient response by Rukmini Kumar, Kannan Thiagarajan, Lakshmanan Jagannathan, Liming Liu, Kapil Mayawala, Dinesh deAlwis, Brian Topp

    Get full text
    Article


  4. 4

    Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee by Charlie Garnett-Benson, Sarah Warren, Anne Monette, Alexandra Snyder, Janis M Taube, J Carl Barrett, Kurt A Schalper, Brian Topp

    Published in Journal for ImmunoTherapy of Cancer (2024-07-01)
    Get full text
    Article


  5. 5

    P1067: ESTIMATING THE RELATIVE EFFICACY OF FAVEZELIMAB WHEN USED IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH PD-1–REFRACTORY CLASSICAL HODGKIN LYMPHOMA by Philippe Armand, Pier Luigi Zinzani, John Timmerman, Nathalie Johnson, David Lavie, Kannan Thiagarajan, Brian Topp, Pallavi Pillai, Alex F. Herrera

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


Search Tools: